AllianceBernstein
GSK icon

AllianceBernstein’s GSK GSK Stock Holding History

AllianceBernstein’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
+4,243
New +$230K ﹤0.01% 3037
2024
Q1 		– Sell
-7,580
Closed -$281K – 3157
2023
Q4 		$281K Buy
+7,580
New +$272K ﹤0.01% 2871
2022
Q3 		– Sell
-699,953
Closed -$38.1M – 3285
2022
Q2 		$38.1M Buy
699,953
+569,420
+436% +$31.4M 0.02% 652
2022
Q1 		$7.11M Sell
130,533
-127,625
-49% -$6.93M ﹤0.01% 1417
2021
Q4 		$14.2M Buy
258,158
+197,697
+327% +$10.3M 0.01% 1079
2021
Q3 		$2.89M Buy
+60,461
New +$3.04M ﹤0.01% 1939
2020
Q1 		– Sell
-4,117
Closed -$242K – 3153
2019
Q4 		$242K Sell
4,117
-157,052
-97% -$8.74M ﹤0.01% 2852
2019
Q3 		$8.6M Buy
161,169
+151,223
+1,520% +$7.78M 0.01% 1111
2019
Q2 		$498K Buy
9,946
+3,496
+54% +$175K ﹤0.01% 2602
2019
Q1 		$337K Buy
+6,450
New +$322K ﹤0.01% 2701
2018
Q2 		– Sell
-120,202
Closed -$5.87M – 3118
2018
Q1 		$5.87M Buy
+120,202
New +$5.6M ﹤0.01% 1130
2016
Q4 		– Sell
-10,491
Closed -$566K – 3023
2016
Q3 		$566K Sell
10,491
-4,512
-30% -$247K ﹤0.01% 2488
2016
Q2 		$813K Sell
15,003
-4,006
-21% -$211K ﹤0.01% 2316
2016
Q1 		$964K Sell
19,009
-3,456
-15% -$172K ﹤0.01% 2121
2015
Q4 		$1.13M Sell
22,465
-14,461
-39% -$737K ﹤0.01% 2052
2015
Q3 		$1.77M Buy
36,926
+1,000
+3% +$52.1K ﹤0.01% 1743
2015
Q2 		$1.87M Sell
35,926
-308,329
-90% -$17.4M ﹤0.01% 1856
2015
Q1 		$19.9M Sell
344,255
-1,991
-0.6% -$114K 0.02% 727
2014
Q4 		$18.5M Sell
346,246
-27,012
-7% -$1.51M 0.02% 724
2014
Q3 		$21.4M Sell
373,258
-1,248,326
-77% -$76.5M 0.02% 674
2014
Q2 		$108M Buy
1,621,584
+2,433
+0.2% +$165K 0.09% 245
2014
Q1 		$108M Buy
1,619,151
+141,785
+10% +$9.59M 0.09% 250
2013
Q4 		$98.6M Buy
1,477,366
+1,188,296
+411% +$77M 0.09% 256
2013
Q3 		$18.1M Buy
289,070
+7,573
+3% +$487K 0.02% 675
2013
Q2 		$17.6M Buy
+281,497
New +$17.9M 0.02% 680

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein's GSK Position: Q1 2026 in Review

AllianceBernstein opened a new position in GSK (GSK) in Q1 2026: 4,243 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #3037 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in GSK as recently as Q4 2023.

AllianceBernstein first reported a position in GSK in Q2 2013 and has held it in 25 quarters since. The position peaked at $108M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • AllianceBernstein held 4,243 shares of GSK worth $208K as of Q1 2026.
  • GSK was a new AllianceBernstein position in Q1 2026.
  • GSK made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3037 holding.
  • AllianceBernstein first reported a position in GSK in Q2 2013 and has held it in 25 quarters since.
  • AllianceBernstein's GSK position peaked at $108M in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.